Circulating long noncoding RNA ANRIL downregulation correlates with increased risk, higher disease severity and elevated pro‐inflammatory cytokines in patients with acute ischemic stroke. Issue 1 (1st August 2018)
- Record Type:
- Journal Article
- Title:
- Circulating long noncoding RNA ANRIL downregulation correlates with increased risk, higher disease severity and elevated pro‐inflammatory cytokines in patients with acute ischemic stroke. Issue 1 (1st August 2018)
- Main Title:
- Circulating long noncoding RNA ANRIL downregulation correlates with increased risk, higher disease severity and elevated pro‐inflammatory cytokines in patients with acute ischemic stroke
- Authors:
- Feng, Lijuan
Guo, Jun
Ai, Fen - Abstract:
- Abstract : Background: To investigate the correlation of plasma lncRNA ANRIL expression with stroke risk, severity and inflammatory cytokines levels in acute ischemic stroke (AIS) patients. Methods: A total of 126 AIS patients and 125 controls were consecutively recruited in this case‐control study. Blood samples from all participants were collected, and plasma was separated. Plasma lncRNA ANRIL expression was quantified by quantitative real‐time polymerase chain reaction (qRT‐PCR). Plasma tumor necrosis factor‐α (TNF‐α) and interleukin (IL)‐1β (IL‐1β), IL‐6, IL‐8, IL‐10, and IL‐17 levels were measured by enzyme‐linked immunosorbent assay (ELISA). National Institutes of Health Stroke Scale (NIHSS) scores were used to assess the stroke severity in AIS patients. Results: Plasma lncRNA ANRIL expression was lower in AIS patients than in controls ( P < 0.001), and the receiver operating characteristic (ROC) curve showed a good prediction value of lncRNA ANRIL for AIS risk with area under curve (AUC) of 0.759 (95% CI: 0.741‐0.849). In addition, lncRNA ANRIL expression was negatively correlated with NIHSS score ( r = −0.351, P < 0.001). Furthermore, while lncRNA ANRIL expression was negatively associated with hs‐CRP level ( r = −0.247, P = 0.005), no correlation was found between lncRNA ANRIL expression and ESR level ( P = 0.619). For inflammatory cytokines, lncRNA ANRIL expression was inversely associated with TNF‐α ( r = −0.216, P = 0.015) and IL‐6 levels ( r = −0.326, PAbstract : Background: To investigate the correlation of plasma lncRNA ANRIL expression with stroke risk, severity and inflammatory cytokines levels in acute ischemic stroke (AIS) patients. Methods: A total of 126 AIS patients and 125 controls were consecutively recruited in this case‐control study. Blood samples from all participants were collected, and plasma was separated. Plasma lncRNA ANRIL expression was quantified by quantitative real‐time polymerase chain reaction (qRT‐PCR). Plasma tumor necrosis factor‐α (TNF‐α) and interleukin (IL)‐1β (IL‐1β), IL‐6, IL‐8, IL‐10, and IL‐17 levels were measured by enzyme‐linked immunosorbent assay (ELISA). National Institutes of Health Stroke Scale (NIHSS) scores were used to assess the stroke severity in AIS patients. Results: Plasma lncRNA ANRIL expression was lower in AIS patients than in controls ( P < 0.001), and the receiver operating characteristic (ROC) curve showed a good prediction value of lncRNA ANRIL for AIS risk with area under curve (AUC) of 0.759 (95% CI: 0.741‐0.849). In addition, lncRNA ANRIL expression was negatively correlated with NIHSS score ( r = −0.351, P < 0.001). Furthermore, while lncRNA ANRIL expression was negatively associated with hs‐CRP level ( r = −0.247, P = 0.005), no correlation was found between lncRNA ANRIL expression and ESR level ( P = 0.619). For inflammatory cytokines, lncRNA ANRIL expression was inversely associated with TNF‐α ( r = −0.216, P = 0.015) and IL‐6 levels ( r = −0.326, P < 0.001), while it positively correlated with IL‐10 level ( r = 0.210, P = 0.018). Conclusion: Circulating lncRNA ANRIL downregulation correlates with increased stroke risk, higher disease severity and elevated inflammation in AIS patients. … (more)
- Is Part Of:
- Journal of clinical laboratory analysis. Volume 33:Issue 1(2019)
- Journal:
- Journal of clinical laboratory analysis
- Issue:
- Volume 33:Issue 1(2019)
- Issue Display:
- Volume 33, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 33
- Issue:
- 1
- Issue Sort Value:
- 2019-0033-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2018-08-01
- Subjects:
- acute ischemic stroke -- inflammatory cytokines -- lncRNA ANRIL -- National Institutes of Health Stroke Scale score -- stroke risk
Diagnosis, Laboratory -- Periodicals
Medical laboratory technology -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/jcla.22629 ↗
- Languages:
- English
- ISSNs:
- 0887-8013
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4958.520000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9451.xml